Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
Claire Gourzonès(Centre National de la Recherche Scientifique), Jérôme Moreaux(Hôpital Saint Eloi)
Cited by 30
Related Papers
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells
|Virology Journal|2010|124
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
|Clinical Epigenetics|2018|47
Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
|BioMed Research International|2014|20